Mixed inhibition of adenosine deaminase activity by 1,3-dinitrobenzene: A Model for understanding cell-selective neurotoxicity in chemically-induced energy deprivation syndromes in brain

Toxicological Sciences

Volumn 125, Issue 2, 2012, Pages 509-521

  Wang, Yipei ^a   Liu, Xin ^a   Schneider, Brandon ^a   Zverina, Elaina A ^a   Russ, Kristen ^a   Wijeyesakere, Sanjeeva J ^b   Fierke, Carol A ^a,b   Richardson, Rudy J ^a,b   Philbert, Martin A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

1,3 dinitrobenzene; Adenosine; Adenosine deaminase; Astrocytes

Indexed keywords

1,3 DINITROBENZENE; ADENOSINE; ADENOSINE DEAMINASE;

ARTICLE; ASTROCYTE; CHEMICAL INJURY; CHEMICALLY INDUCED ENERGY DEPRIVATION SYNDROME; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INHIBITION; GEL ELECTROPHORESIS; HUMAN; HYPOXIA; IC 50; INHIBITION KINETICS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN;

BOVINAE;

EID: 84862937411     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr317     Document Type: Article

References (49)

1. Alunni, S., Orru, M., and Ottavi, L. (2008). A study on the inhibition of adenosine deaminase. J. Enzyme Inhib. Med. Chem. 23, 182-189.
2. Blackburn, D. M., Gray, A. J., Lloyd, S. C., Sheard, C. M., and Foster, P. M. (1988). A comparison of the effects of the three isomers of dinitrobenzene on the testis in the rat. Toxicol. Appl. Pharmacol. 92, 54-64.
3. Bond, J. A., Chism, J. P., Rickert, D. E., and Popp, J. A. (1981). Induction of hepatic and testicular lesions in Fischer-344 rats by single oral doses of nitrobenzene. Fundam. Appl. Toxicol. 1, 389-394.
4. Brown, C. D., and Miller, M. G. (1991). Effect of culture age on 1,3-dinitrobenzene metabolism and indicators of cellular toxicity in rat testicular cells. Toxicol. In Vitro 5, 269-275.
5. Burnstock, G. (2006). Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27, 166-176.
6. Butina, D. (1999). Unsupervised data base clustering based on Daylight's ngerprint and Tanimoto similarity: A fast and automated way to cluster small and large data sets. J. Chem. Inf. Comput. Sci. 39, 747-750.
7. Cody, T. E., Witherup, S., Hastings, L., Stemmer, K., and Christian, R. T. (1981). 1,3-Dinitrobenzene: Toxic effects in vivo and in vitro. J. Toxicol. Environ. Health 7, 829-847.
8. Coligan, J. E. (1996). One-dimensional electrophoresis using nondenaturing conditions. In Current Protocols in Protein Science (J. Coligan, B. Dunn, H. Ploegh, D. Speicher and P. Wingeld, Eds.), pp. 10.3.1-10.3.11. John Wiley and Sons, New York, NY.
9. Cristalli, G., Costanzi, S., Lambertucci, C., Lupidi, G., Vittori, S., Volpini, R., and Camaioni, E. (2001). Adenosine deaminase: Functional implications and different classes of inhibitors. Med. Res. Rev. 21, 105-128.
10. Duan, Y.,Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang,W., Yang, R., Cieplak, P., Luo, R., Lee, T., et al. (2003). A point-charge force eld for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24, 1999-2012.
11. Ferrara, P., Gohlke, H., Price, D. J., Klebe, G., and Brooks, C. L. (2004). Assessing scoring functions for protein-ligand interactions. J. Med. Chem. 47, 3032-3047.
12. Fredholm, B. B. (2007). Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14, 1315-1323.
13. Fredholm, B. B., Chen, J. F., Masino, S. A., and Vaugeois, J. M. (2005). Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45, 385-412.
14. Frenguelli, B. G., Llaudet, E., and Dale, N. (2003). High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J. Neurochem. 86, 1506-1515.
15. Frick, L., Wolfenden, R., Smal, E., and Baker, D. C. (1986). Transition-state stabilization by adenosine deaminase: Structural studies of its inhibitory complex with deoxycoformycin. Biochemistry 25, 1616-1621.
16. Gracia, E., Cortés, A., Meana, J. J., García-Sevilla, J., Hersheld, M. S., Canela, E. I., Mallol, J., Lluis, C., Franco, R., and Casadó, V. (2008). Human adenosine deaminase as an allosteric modulator of human A(1) adenosine receptor: Abolishment of negative cooperativity for [H-3](R)-pia binding to the caudate nucleus. J. Neurochem. 107, 161-170.
17. Hu, H. L., Bennett, N., Lamb, J. H., GhersiEgea, J. F., Schlosshauer, B., and Ray, D. E. (1997). Capacity of rat brain to metabolize m-dinitrobenzene: An in vitro study. Neurotoxicology 18, 363-370.
18. Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Gimenez-Llort, L., Escorihuela, R. M., Fernandez-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X. J., et al. (2001). Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 9407-9412.
19. Kaplan, N. O. (1955). Specic adenosine deaminase from intestine. Methods Enzymol. 2, 473-475.
20. Kinoshita, T., Nakanishi, I., Terasaka, T., Kuno, M., Seki, N., Warizaya, M., Matsumura, H., Inoue, T., Takano, K., Adachi, H., et al. (2005). Structural basis of compound recognition by adenosine deaminase. Biochemistry 44, 10562-10569.
21. Kinoshita, T., Tada, T., and Nakanishi, I. (2008). Conformational change of adenosine deaminase during ligand-exchange in a crystal. Biochem. Biophys. Res. Commun. 373, 53-57.
22. Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., and Vriend, G. (2004). Making optimal use of empirical energy functions: Force-eld parameter-ization in crystal space. Proteins 57, 678-683.
23. Kurz, L. C., Moix, L., Riley, M. C., and Frieden, C. (1992). The rate of formation of transition-state analogues in the active site of adenosine deaminase is encounter-controlled: Implications for the mechanism. Biochemistry 31, 39-48.
24. Latini, S., and Pedata, F. (2001). Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J. Neurochem. 79, 463-484.
25. Lee, H. B., and Blaufox, M. D. (1985). Blood volume in the rat. J. Nucl. Med. 26, 72-76.
26. Mavroudis, G., Prior, M. J., Lister, T., Nolan, C. C., and Ray, D. E. (2006). Neurochemical and oedematous changes in 1,3-dinitrobenzene-induced astroglial injury in rat brain from a 1H-nuclear magnetic resonance perspective. J. Neural Transm. 113, 1263-1278.
27. Miller, J. A., Runkle, S. A., Tjalkens, R. B., and Philbert, M. A. (2011). 1,3-Dinitrobenzene induced metabolic impairment through selective inactivation of the pyruvate dehydrogenase complex. Toxicol. Sci. 122, 502-511
28. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639-1662.
29. North, R. A., and Verkhratsky, A. (2006). Purinergic transmission in the central nervous system. Pugers Arch. 452, 479-485.
30. Pal, D., and Chakrabarti, P. (1999). Cis peptide bonds in proteins: residues involved, their conformations, interactions and locations. J. Mol. Biol. 294, 271-288.
31. Pak, M. A., Haas, H. L., Decking, U. K., and Schrader, J. (1994). Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology 33, 1049-1053.
32. Parkinson, F. E., Xiong,W., and Zamzow, C. R. (2005). Astrocytes and neurons: Different roles in regulating adenosine levels. Neurol. Res. 27, 153-160.
33. Phelka, A. D., Beck, M. J., and Philbert, M. A. (2003). 1,3-Dinitrobenzene inhibits mitochondrial complex II in rat and mouse brainstem and cortical astrocytes. Neurotoxicology 24, 403-415.
34. Philbert, M. A., Nolan, C. C., Cremer, J. E., Tucker, D., and Brown, A. W. (1987). 1,3-Dinitrobenzene-induced encephalopathy in rats. Neuropathol. Appl. Neurobiol. 13, 371-389.
35. Phillips, E., and Newsholme, E. A. (1979). Maximum activities, properties and distribution of 5' nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J. Neurochem. 33, 553-558.
36. Prinz, H. (2009). Hill coefcients, dose-response curves and allosteric mechanisms. J. Chem. Biol. 3, 37-44.
37. Reeve, I. T., and Miller, M. G. (2002). 1,3-Dinitrobenzene metabolism and protein binding. Chem. Res. Toxicol. 15, 352-360.
38. Ribeiro, J. A., and Sebastiao, A. M. (2010). Modulation and metamodulation of synapses by adenosine. Acta Physiol. (Oxf.) 199, 161-169.
39. Romero, I. A., Lister, T., Richards, H. K., Seville, M. P., Wylie, S. P., and Ray, D. E. (1995). Early metabolic changes during m-dinitrobenzene neurotoxicity and the possible role of oxidative stress. Free Radic. Biol. Med. 18, 311-319.
40. Seidler, J., McGovern, S. L., Doman, T. N., and Shoichet, B. K. (2003). Identication and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46, 4477-4486.
41. Steiner, S. R., and Philbert, M. A. (2011). Proteomic identication of carbonylated proteins in 1,3-dinitrobenzene neurotoxicity. Neurotoxicology 32, 362-373.
42. Stone, T. W., Ceruti, S., and Abbracchio, M. P. (2009). Adenosine receptors and neurological disease: Neuroprotection and neurodegeneration. Handb. Exp. Pharmacol. 193, 535-587.
43. Takahashi, T., Otsuguro, K., Ohta, T., and Ito, S. (2010). Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats. Br. J. Pharmacol. 161, 1806-1816.
44. Tjalkens, R. B., Ewing, M. M., and Philbert, M. A. (2000). Differential cellular regulation of the mitochondrial permeability transition in an in vitro model of 1,3-dinitrobenzene-induced encephalopathy. Brain Res. 874, 165-177.
45. Wang, S. H., Wang, S. F., Xuan, W., Zeng, Z. H., Jin, J. Y., Ma, J., and Tian, G. R. (2008). Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A. Bioorg. Med. Chem. 16, 3596-3601.
46. Williams, E. S., Phelka, A., Ray, D. E., and Philbert, M. A. (2005). Astrocytes in Acute Energy Deprivation Syndromes, 2nd ed, pp. 237-250. CRC Press, Boca Raton, FL.
47. Wolfenden, R., and Snider, M. J. (2001). The depth of chemical time and the power of enzymes as catalysts. Acc. Chem. Res. 34, 938-945.
48. Xu, J., Nolan, C. C., Lister, T., Purcell, W. M., and Ray, D. E. (1999). Pharmacokinetic factors and concentration-time threshold in m-dinitroben-zene-induced neurotoxicity. Toxicol. Appl. Pharmacol. 161, 267-273.
49. Xu, Y. D., and Venton, B. J. (2010). Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry. Phys. Chem. Chem. Phys. 12, 10027-10032.